Motilal Oswal’s 19th Wealth Creation Study makes it clear that finding 100-bagger stocks is not a matter of chance. Instead, potential 100-baggers reveal definite characteristics and it is possible to identify them much in advance
Posts in category Mid Cap
Ramesh Damani & PN Vijay Bask In 4-Bagger Profits From NBCC. Nomura Promises More Gains From It
NBCC, a humble PSU, has led to enormous wealth creation for the savvy investors who spotted its potential early on. Luckily, there is still a chance for us to make amends if you go by Nomura’s revised price target
Brigade Enterprises Is A Value Pick With 59% Upside Potential: HDFC Sec
HDFC Sec has released an “Initiating Coverage” report on Brigade Enterprises claiming that the value of operational assets is more than the market cap and that stock has a potential upside of 59%
V-Mart Retail Has 56% Upside Potential: Nirmal Bang
Nirmal Bang has issued an Initiating Coverage report on V-Mart Retail claiming that the company has great potential and an upside potential of 56%
Eight Large-Cap + Mid-Cap Stock Recommendations From Kotak
Kotak Securities has identified eight stock ideas from the large-cap and mid-cap space which they claim have the potential to outperform
Daljeet Kohli Makes A Packet from OnMobile Global & Pennar Industries. Sees More Gains From Them
Daljeet Kohli’s latest stock picks, OnMobile Global and Pennar Industries, are steadily churning out gains for investors. He has issued an update promising more gains from these stocks
Twenty Large-Cap & Mid-Cap Stock Ideas From Sharekhan (Dec 2014)
Sharekhan has carefully analyzed the prospects of twenty large-cap and mid-cap stocks and given advice on whether the stocks should be bought or held for the long-term as part of the portfolio
Credit Suisse Identifies Top Pick Stocks That Are Still Cheap And Will Outperform
If you are feeling jittery that stocks are now too expensive, you have to read the advisory issued by Credit Suisse. Credit Suisse has confirmed that India will see the strongest earnings growth in Asia and that Indian markets not expensive. They have also identified their top picks that they are confident will outperform
Sharon Bio-Medicine Has 174%+ Upside: Daljeet Kohli
Daljeet Kohli of IndiaNivesh has issued an update report pointing out that the 40% correction in the stock has made the stock attractive in terms of valuation. He has foreseen a target of Rs. 140 for the stock and advised investors to wait for the results of key near term triggers
Wealth Creator Portfolio By Sharekhan Gives Huge Gains
Sharekhan has released a “Wealth Creator” portfolio which has stocks of top quality companies expected to do well in the next few years
Recent Comments